Antonio D'Alessio/X
Jan 26, 2025, 21:55
Antonio D’Alessio: 9 year follow-up of adjuvant cell therapy for HCC at ASCOGI25
Antonio D’Alessio, Medical Oncologist and PhD student at Imperial College London, shared on X:
“Do you remember adjuvant cell therapy for HCC? At ASCOGI25 the NINE year (!) follow-up was presented:
maintained significant RFS benefit
reduction in cancer-specific death
increase in CD8+ memory T cells
Adjuvant therapy for HCC: not everything is lost ?”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 26, 2025, 21:56
Jan 26, 2025, 21:55
Jan 26, 2025, 21:55
Jan 26, 2025, 21:55
Jan 26, 2025, 21:55
Jan 26, 2025, 17:30
Jan 26, 2025, 17:23
Jan 26, 2025, 17:19